Data
Satellos Biosciences moves toward Nasdaq: Intent announced
Satellos Biosciences (SATLF) reached "Intent announced" on its path from OTC to Nasdaq.
Last updated: October 17, 2026, 8:20 AM ET· SATLF profile
Stage records come from the company's own releases and EDGAR filings; each is linked below. Nothing here predicts whether the listing completes.
The data
| Metric | Value |
|---|---|
| From → To | OTC → Nasdaq |
| Stage | Intent announced |
| Share price since announcement | -15.9% |
| Average volume, before → after | 1,014 → 3,918 |
| Insider buys, 90 days | 0 |
| Requirements check | Minimum bid price: meets; Market value of public float: meets; Publicly held shares: meets |
Stage history
Intent announced: 2026-01-28
The bottom line
Requirements are shown as meets or below against the exchange rulebook; they are facts about thresholds, not advice.